| Apr 29, 2013 |
Apr 27, 2015 |
ELITE PHARMACEUTICALS INC /NV/
|
Director |
Sell |
36.3
|
-140,000
|
-0.57%
|
✗
|
$11.2K |
| May 9, 2013 |
May 13, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
10% Owner |
Sell |
26.3
|
-391,500
|
-2.51%
|
✗
|
$27.8K |
| Apr 26, 2013 |
Apr 30, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
10% Owner |
Buy |
95.0
|
+4,455,827
|
39.89%
|
✗
|
$164.4K |
| Apr 25, 2013 |
Apr 30, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
10% Owner |
Sell |
20.0
|
-13,891,407
|
-15.93%
|
✗
|
$535.2K |
| Mar 25, 2013 |
Mar 27, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
10% Owner |
Buy |
90.0
|
+1,355,014
|
8.76%
|
✗
|
$50K |
| Mar 21, 2013 |
Mar 25, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
10% Owner |
Sell |
20.0
|
-13,550,136
|
-46.68%
|
✗
|
$500K |
| Jan 22, 2013 |
Jan 25, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
10% Owner |
Sell |
26.3
|
-356,700
|
-2.69%
|
✗
|
$32.1K |
| Jan 11, 2013 |
Jan 14, 2013 |
ELITE PHARMACEUTICALS INC /NV/
|
10% Owner |
Sell |
22.5
|
-2,339,000
|
-24.47%
|
✗
|
$211.9K |
| Dec 26, 2012 |
Dec 31, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Director |
Sell |
22.5
|
-561,000
|
-5.54%
|
✗
|
$50.9K |
| Dec 19, 2012 |
Dec 21, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Director |
Sell |
20.0
|
-17,248,700
|
-63.02%
|
✗
|
$649.8K |
| May 4, 2012 |
May 4, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Director |
Sell |
20.0
|
-9,214,097
|
-25.19%
|
✗
|
$340K |
| Mar 23, 2012 |
Mar 27, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Director |
Sell |
20.0
|
-2,725,000
|
-4.29%
|
✗
|
$256.5K |
| Mar 14, 2012 |
Mar 20, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Director |
Sell |
52.5
|
-85,000
|
-0.13%
|
✗
|
$8.5K |
| Jan 26, 2012 |
Jan 30, 2012 |
ELITE PHARMACEUTICALS INC /NV/
|
Director |
Sell |
26.3
|
-407,949
|
-12.05%
|
✗
|
$49K |
| Feb 3, 2011 |
Mar 17, 2011 |
ELITE PHARMACEUTICALS INC /NV/
|
Director |
Buy |
91.3
|
+407,949
|
453.28%
|
✗
|
$16.3K |